Login to Your Account

EMBL Ventures Gets $54M in First Closing of Second Fund

By Cormac Sheridan
BioWorld International Correspondent

Wednesday, December 14, 2011
EMBL Ventures GmbH took in €40 million (US$53.5 million) in a first closing of its second fund, bringing an additional tranche of early stage investment to Germany's cash-starved biotechnology sector. And it hopes to add at least another €10 million in a second closing.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription